Document ID: chunk:federal_register_of_legislation:F2022L00661:reg:7
Version: federal_register_of_legislation:F2022L00661
Segment Type: reg
Provision Reference: reg 7
Character Range: 1678–3475

7             Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about malignant neoplasm of the larynx and death from malignant neoplasm of the larynx.
Meaning of malignant neoplasm of the larynx
(2)          For the purposes of this Statement of Principles, malignant neoplasm of the larynx:
(a)          means a primary malignancy of the mucosa of the larynx, which extends from the lower border of the hypopharynx to the upper border of the trachea; and
(b)          excludes:
(i)            carcinoid tumour;
(ii)         Hodgkin's lymphoma;
(iii)       non-Hodgkin lymphoma; and
(iv)        soft tissue sarcoma.
               Note: The larynx is divided anatomically into three sections: the supraglottis, glottis and subglottis (infraglottis).
(3)          While malignant neoplasm of the larynx attracts ICD‑10‑AM code C32, in applying this Statement of Principles the meaning of malignant neoplasm of the larynx is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from malignant neoplasm of the larynx
(5)          For the purposes of this Statement of Principles, malignant neoplasm of the larynx, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's malignant neoplasm of the larynx.
Note: terminal event is defined in the Schedule 1 - Dictionary.